- Original article
- Open access
- Published:
Adiponectin and ghrelin: nutritional regulatory role in chronic kidney disease patients
The Egyptian Journal of Internal Medicine volume 31, pages 99–105 (2019)
Abstract
Background
Adiponectin and ghrelin are orexigenic hormones involved in the regulation of appetite in kidney disease patients. The aim of the study is to investigate the plasma concentration of total adiponectin and ghrelin in hemodialysis (HD) patients, kidney transplant recipients (KTRs), and chronic kidney disease (CKD) patients not yet on regular dialysis.
Patients and methods
2The study included 180 patients with a mean age of 34.6±9.53 who were enrolled from the Nephrology Department of Cairo Medical School. Group 1 included 60 HD patients; group 2 included 60 KTRs. Group 3 included 60 participants with CKD not yet on dialysis. Anthropometric measures of all patients were taken. All participants were investigated for adiponectin, ghrelin, lipid profile, albumin, and hemoglobin. Adiponectin and ghrelin were correlated with variable parameters.
Results
One hundred and eight patients (60%) were men. Adiponectin was significantly higher in HD patients than KTRs and CKD groups (17±3.5, 10.8±5.2, and 4.7±2.3, respectively). Ghrelin was lower in KTRs compared with HD and CKD groups (2.1 ±0.2, 2.8±0.25, 2.8±0.3, respectively, P<0.001). Adiponectin and ghrelin were inversely correlated with BMI in all studied groups.
Conclusion
Adiponectin and ghrelin levels were highest in HD patients. Adiponectin was superior to ghrelin as a positive predictor of nutritional status in CKD.
References
Alice S, Giuseppe R, Marco D, Tommaso DM, Chiara C, Sarah P, et al. Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in end-stage renal disease patients on hemodialysis. Clin Nutr 2018; 19:S0261–5614.
Guebre-Egziabher F, Bernhard J, Geelen G, Malvoisin E, Hadj-Aissa A, Fouque D. Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease. J Ren Nutr 2005; 15:116–120.
Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117:13–23.
Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2017; 20:129–134.
Heidari M, Nasri P, Nasri H. Adiponectin and chronic kidney disease; a review on recent findings. J Nephropharmacol 2015; 4:63–68.
Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 2014; 15:6184–6223.
Christou G, Kiortsis D. The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 2014; 221:R49–R61.
Rhee CM, Nguyen DV, Moradi H, Brunelli SM, Dukkipati R, Jing J, et al. Association of adiponectin with body composition and mortality in hemodialysis patients. Am J Kidney Dis 2015; 66:313–321.
Stengel A, Taché Y. Ghrelin – a pleiotropic hormone secreted from endocrine X/A-like cells of the stomach. Front Neurosci 2102; 6:1–15.
Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasu H, Yahata K, et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000; 486:213–216.
Delporte C. Structure and physiological actions of ghrelin. Scientifica (Cairo) 2013; 2013:1–25.
Gunta SS, Mak RH. Ghrelin and leptin pathophysiology in chronic kidney disease. Pediatr Nephrol 2013; 28:611–616.
Christine KA, Klöckener TC, Brüning J. Control of energy homeostasis by insulin and leptin: Targeting the arcuate nucleus and beyond. Physiol Behav 2009; 97:632–638.
Chung S, Koh ES, Shin SJ, Park CW. Malnutrition in patients with chronic kidney disease. Open J Intern Med 2012; 02:89–99.
Pupim LB, Cuppari L, Ikizler TA. Nutrition and metabolism in kidney disease. Semin Nephrol 2006; 26:134–157.
Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612.
Kopple JD. McCollum. Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 1997; 65:1544–1557.
Anja KA, Rainer B, Stephan P, Berthold PH, Klause M, Peter FH. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 2009; 24:643–646.
Ocak N, Dirican M, Ersoy A, Sarandol E. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure. Ren Fail 2016; 38:1639–1646.
Chan CM. Hyperlipidemia in chronic kidney disease. Ann Acad Med Singapore 2005; 35:31–35.
Suleiman B, El Imam M, Elsabigh M, Eltahir K, Eltahir A, Miskeen E. Lipid profile in post renal transplant patients treated with cyclosporine in Sudan. Saudi J Kidney Dis Transplant 2009; 20:312–317.
Razeghi E, Shafipour M, Ashraf H, Pourmand G. Lipid disturbances before and after renal transplant. Exp Clin Transplant 2011; 9:230–235.
Chudek J, Adamczak M, Karkoszka H, Budzinski G, Ignacy W, Funahashi T, et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003; 35:2186–2189.
Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 2003; 63:S98–S102.
Leibowitz A, Peleg E, Sharabi Y, Kamari Y. Normal adiponectin levels in kidney transplant patients with hypertension. Kidney Int 2013; 27:562–566.
Alam A, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Kalantar-Zadeh K, et al. Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol 2013; 8:460–467.
Nagy K, Nagaraju SP, Rhee CM, Mathe Z, Molnar MZ. Adipocytokines in renal transplant recipients. Clin Kidney J 2016; 9:359–373.
Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, et al. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr 2012; 22:258–267.
Iglesias P, Díez JJ, Fernández-Reyes M, Codoceo R, Alvarez-Fidalgo P, Bajo MA, Aguilera A, Selgas R. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 2006; 64:68–73.
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459–469.
Ayala ER, Pecoits-Filho R, Heimbürger O, Lindholm B, Nordfors L, Stenvinkel P. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 2004; 19:421–426.
Elsayed N, Hamed S, El-Khatib M, El-shehaby A. The relation between dual energy x-ray absorptiometry measurement of body fat composition and plasma ghrelin in patients with end-stage renal disease. Saudi Med J 2009; 30:109–115.
Genís BB, Granada ML, Alonso N, Lauzurica R, Jiménez JA, Barluenga E, et al. Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation. Transplantation 2007; 84:1248–1254.
Monzani A, Perrone M, Prodam F, Moia S, Genoni G, Testa S, et al. Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease. Pediatr Nephrol 2018; 33:661–672.
Muscaritoli M, Molfino A, Chiappini MG, Laviano A, Ammann T, Spinsanti P, et al. Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol 2007; 27:360–365.
Sedighi O, Abediankenari S. Relationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease. Nephrourol Mon 2014; 6:e11743.
Stepien M, Stępień A, Wlazel R, Paradowski M, Banach M, Rysz M, et al. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease. Med Sci Monit 2013; 19:1063–1072.
Guenther M, James R, Marks J, Zhao S, Szabo A, Kidambi S. Adiposity distribution influences circulating adiponectin levels. Transl Res 2014; 164:270–277.
Kamimura AM, Canziani FM, Sanches RF, Velludo MC, Carrero JJ, Bazanelli AP, et al. Variations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months. J Bras Nefrol 2012; 34:259–265.
Ho KJ, Xue H, Mauro CR, Nguyen B, Yu P, Tao M, et al. Impact of uremia on human adipose tissue phenotype. J Surg Res 2013; 179:175–182.
Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2599–2606.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
El-Khashab, S.O., Behiry, M.E. Adiponectin and ghrelin: nutritional regulatory role in chronic kidney disease patients. Egypt J Intern Med 31, 99–105 (2019). https://doi.org/10.4103/ejim.ejim_78_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_78_18